Zusammenfassung
Nach langen Diskussionen bietet das Transplantationsgesetz, das am 01.12.1997 in Kraft trat, Rechtssicherheit. Das Gesetz dient dem Schutz des Spenders und des Empfängers, und es bietet Rechtssicherheit für alle in der Transplantationsmedizin Tätigen. Das Gesetz legt die Rechte und Verpflichtungen der Be teiligten und die Wege der Organspende und -vermittlung fest Das Gesetz unterscheidet zwischen der Organentnahme bei Lebenden und bei Verstorbenen und legt die Rahmenbedingungen fest. Die Umsetzung der Todesbestimmung soll nach den Erkenntnissen der medizinischen Wissenschaft erfolgen und ist in den Richtlinien der Bundesärztekammer (3. Fortschreibung 1997) festgelegt worden.
Chapter PDF
Literatur
Kuse E,Weimann A (1994) Besonderheiten im Rahmen derTransplantationschirurgie. In: Hartig W (Hrsg) Moderne Infusionstherapie - Künstliche Ernährung. Zuckschwert, München, S 529 - 534
Wiesner RH et al. (1988) Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 45: 570 - 574
Ozawa K, Mori K, Morimoto T (1994) Evaluation of hepatic function. Curr Opin Gen Surg 17 - 23
Wade JJ et al. (1995) Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 21: 1328 - 1336
Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden 0 (1995) Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study.Transplantation 59: 45 - 50
Kusne S. et al. (1999) Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 68: 1125 - 1131
Liebau P et al. (1996) Management of herpes simplex virus type 1 pneumonia following liver transplantation. Infection 24: 130 - 135
Schlitt H1 et al. (1991) Differentiation of liver graft dysfunction by transplant aspiration cytology.Transplantation 51: 786 - 793
Egawa H et al. (1999) Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications.Transplantation 67: 712 - 717
Blanco R, De Girolami U, Jenkins RL, Khettry U (1995) Neuropathology of liver transplantation. Clin Neuropathol 14: 109 - 117
Lee YJ et al. (1996) Neurologic complications after orthotopic liver transplantation including central pontine myelinolysis. Transplant Proc 28: 1674 - 1675
Humar A et al. (1999) The association between acute rejection and chronic rejection in kidneytransplantation.Transplant Proc 31: 1302 - 1303
MacMillan N et al. (1998) Venous graft thrombosis in clinical pancreas transplantation: options for a rescue treatment. Transplant Proc 30: 425 - 426
Smets YF et al. (1997) Infectious disease complications of simultaneous pancreas kidney transplantation. Nephrol Dial Transplant 12: 764 - 771
Glogar D et al. (1990) Heart transplantation: indication, selection criteria and patient management. Wien Med Wochenschr 140: 287 - 289
Kobashigawa JA (1998) Advances in immunosuppression for heart transplantation. Adv Card Surg 10: 155 - 174
Golshayan D et al. (1998) Incidence and prognostic value of electrocardiographic abnormalities after heart transplantation. Clin Cardiol 21: 680 - 684
RourkeTK, Droogan MT, Ohler L (1999) Heart transplantation: state of the art. AACN Clin Issues 10: 185 - 201
Hammer Set al. (1998) Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation.Transpl Immunol 6: 235 - 241
De Maria R et al. (1996) Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.) Heart Lung Transplant 15: 124 - 135
Frimat L et al. (1998) Treatment of end-stage renal failure after heart transplantation. Nephrol Dial Transplant 13: 2905 - 2908
Edelman JD, Kotloff RM (1997) Lung transplantation. A disease-specific approach. Clin Chest Med 18: 627-644
Hausen B, Morris RE (1997) Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies. Clin Chest Med 18: 353-366
Struber M, Hirt SW, Cramer J, Harringer W, Haverich A (1999) Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 25: 862 - 864
Verleden GM et al. (1999) Cyclophosphamide rescue therapy for chronic rejection after lung transplantation. J Heart Lung Transplant 18: 1139 - 1142
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kuse, ER. (2004). Intensivtherapie nach Organtransplantation. In: Burchardi, H., Larsen, R., Schuster, HP., Suter, P.M. (eds) Die Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-06654-6_74
Download citation
DOI: https://doi.org/10.1007/978-3-662-06654-6_74
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-06655-3
Online ISBN: 978-3-662-06654-6
eBook Packages: Springer Book Archive